Skip to content

Evaluation of Cardiac Alterations in Tooth Removal Surgery

Evaluation of Clinical Parameters in Cardiac patients receiving Local Anesthetics with Vasoconstrictors in Oral Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-96wmytm
Enrollment
Unknown
Registered
2023-03-27
Start date
2021-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Rate

Interventions

A controlled clinical trial was developed to evaluate the cardiovascular effects of local anesthetic Lidocaine 2% with Epinephrine 1:100.000 in healthy and hypertensive patients undergoing teeth extra
E03.155.086.231

Sponsors

Hospital Universitário Onofre Lopes
Lead Sponsor
Departamento de Odontologia da UFRN
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Healthy patients; hypertensive patients; patients in need for tooth removal surgery

Exclusion criteria

Exclusion criteria: Patients that did not agree with research protocol as stablished in the consent form; patients allergic to the medications used in the research; patients with medical conditions that contraindicated a surgical procedure in an ambulatory facility

Design outcomes

Primary

MeasureTime frame
Expected outcome 1: Higher increase in heart rate, oxygen saturation and systolic and diastolic blood pressure measured in the three different moments (preoperative, trans operative and postoperative) for the hypertensive patients. The Mann-Whitney test will be used to identify differences between the experimental and control groups. For the intra group assesment of repeated measures (initial, trans and final), the Friedman test with the adjusted Wilcoxon test will be used. P value inferior to 0,05 will be considered statistically significant.;Expected outcome 2: Higher increase in serum cathecolamines concentration (dopamine, norepinefrin and apinefrin) measured in the three different moments (preoperative, trans operative and postoperative) for the hypertensive patients. The Mann-Whitney test will be used to identify differences between the experimental and control groups. For the intra group assesment of repeated measures (initial, trans and final), the Friedman test with the adjusted Wilcoxon test will be used. P value inferior to 0,05 will be considered statistically significant.;Expected outcome 3: Higher increase in ventricular and supraventricular extrasystoles and in ST segment depression frequencies measured in three different moments (preoperative, trans operative and postoperative) with the Holter device The Mann-Whitney test will be used to identify differences between the experimental and control groups. For the intra group assesment of repeated measures (initial, trans and final), the Friedman test with the adjusted Wilcoxon test will be used. P value inferior to 0,05 will be considered statistically significant.

Secondary

MeasureTime frame
Secondary outcomes are not expected.

Countries

Brazil

Contacts

Public ContactMarcelo Silveira

Universidade Federal do Rio Grande do Norte

marceints@hotmail.com+558432154130

Outcome results

None listed

Source: REBEC (via WHO ICTRP)